These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2277450)

  • 21. Striatal D2/acetylcholine interactions: PET studies of the vesamicol receptor.
    Ingvar M; Stone-Elander S; Rogers GA; Johansson B; Eriksson L; Parsons SM; Widén L
    Neuroreport; 1993 Sep; 4(12):1311-4. PubMed ID: 8260611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The brain cholinergic system in ageing mammals.
    Pepeu G; Casamenti F; Pepeu IM; Scali C
    J Reprod Fertil Suppl; 1993; 46():155-62. PubMed ID: 8315616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasticity and neurotransmitter receptor changes in Alzheimer's disease and experimental cortical infarcts.
    Zilles K; Qü M; Schleicher A; Schroeter M; Kraemer M; Witte OW
    Arzneimittelforschung; 1995 Mar; 45(3A):361-6. PubMed ID: 7763327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
    Mufson EJ; Jaffar S; Levey AI
    J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models.
    Chandra JN; Malviya M; Sadashiva CT; Subhash MN; Rangappa KS
    Neurochem Int; 2008 Feb; 52(3):376-83. PubMed ID: 17719699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-dependent changes in rat brain cholinergic receptor expression after experimental brain injury.
    Verbois SL; Scheff SW; Pauly JR
    J Neurotrauma; 2002 Dec; 19(12):1569-85. PubMed ID: 12542858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats.
    Hernandez CM; Gearhart DA; Parikh V; Hohnadel EJ; Davis LW; Middlemore ML; Warsi SP; Waller JL; Terry AV
    J Pharmacol Exp Ther; 2006 Feb; 316(2):679-94. PubMed ID: 16214877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biphasic effect of tacrine on acetylcholine release in rat brain via M1 and M2 receptors.
    Svensson AL; Zhang X; Nordberg A
    Brain Res; 1996 Jul; 726(1-2):207-12. PubMed ID: 8836562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catecholamine and acetylcholine in the rat cerebral cortex with special reference to pathogenetic mechanisms of Alzheimer's disease.
    Shiosaka S; Yamano M; Tsuchiyama M; Kudo Y; Imaizumi K; Tohyama M
    Gerontology; 1991; 37 Suppl 1():17-23. PubMed ID: 1937065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological characterization of the acetylcholine transport system in purified Torpedo electric organ synaptic vesicles.
    Anderson DC; King SC; Parsons SM
    Mol Pharmacol; 1983 Jul; 24(1):48-54. PubMed ID: 6865925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [3H]acetylcholine and [3H](-)nicotine label the same recognition site in rat brain.
    Martino-Barrows AM; Kellar KJ
    Mol Pharmacol; 1987 Feb; 31(2):169-74. PubMed ID: 3807893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
    Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
    Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscarinic receptor subtypes in human neurodegenerative disorders: focus on Alzheimer's disease.
    Quirion R; Aubert I; Lapchak PA; Schaum RP; Teolis S; Gauthier S; Araujo DM
    Trends Pharmacol Sci; 1989 Dec; Suppl():80-4. PubMed ID: 2694529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of functional cholinergic innervation in rat heart with a novel vesamicol receptor ligand.
    Coffeen PR; Efange SM; Haidet GC; McKnite S; Langason RB; Khare AB; Pennington J; Lurie KG
    Nucl Med Biol; 1996 Oct; 23(7):923-6. PubMed ID: 8971861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo characterization of radioiodinated 2-(4-phenylpiperidino)cyclohexanol (vesamicol) analogs: potential radioligand for mapping presynaptic cholinergic neurons.
    Shiba K; Mori H; Matsuda H; Tsuji S; Tonami N; Hisada K
    Nucl Med Biol; 1995 Aug; 22(6):823-8. PubMed ID: 8535345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phospholipid metabolism in Alzheimer's disease and in a human cholinergic cell.
    Kanfer JN; Singh IN; Pettegrew JW; McCartney DG; Sorrentino G
    J Lipid Mediat Cell Signal; 1996 Sep; 14(1-3):361-3. PubMed ID: 8906582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinergic toxins and Alzheimer's disease.
    Hanin I
    Ann N Y Acad Sci; 1992 May; 648():63-70. PubMed ID: 1637073
    [No Abstract]   [Full Text] [Related]  

  • 39. A positive-feedback model for the loss of acetylcholine in Alzheimer's disease.
    Ehrenstein G; Galdzicki Z; Lange GD
    Ann N Y Acad Sci; 2000; 899():283-91. PubMed ID: 10863547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cholinergic receptor system of the human brain: neurochemical and pharmacological aspects in aging and Alzheimer.
    Giacobini E; DeSarno P; Clark B; McIlhany M
    Prog Brain Res; 1989; 79():335-43. PubMed ID: 2685904
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.